Announcement on Preliminary Earnings Estimate for 2025
Filed with SSE · · 3 pages · Chinese
Jiangsu Aidea Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jiangsu Aidea Pharmaceutical
- Announcement on Using Temporarily Idle Raised Funds for Cash Management
- Announcement on Early Return of Remaining Idle Raised Funds Used to Temporarily Supplement Current Capital
- Earnings Preannouncement for 2025
- Announcement on Voluntary Disclosure of Notice of Approval for Drug Clinical Trial Application Obtained by ADC205 Tablets
- Indicative Announcement on Disclosure of Plan for Issuing A-Shares to Specific Objects by Summary Procedures in 2026
Later from Jiangsu Aidea Pharmaceutical
- Announcement on Share Increase Plan of Actual Controller
- Announcement on Penalties or Regulatory Measures Imposed by Securities Regulatory Authorities and Stock Exchanges in the Recent Five Years
- Announcement on Voluntary Disclosure of Obtained Patent Certificates in Japan
- Announcement on Cancellation of Special Settlement Accounts for Some Raised Fund Financial Products
- Announcement on Remuneration Plan for Directors and Senior Management Members for 2026
Follow Jiangsu Aidea Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Aidea Pharmaceutical